Levofloxacin: Serum bactericidal activity against methicillin-resistant Staphylococcus aureus isolates

Journal of Antimicrobial Chemotherapy

Volumn 43, Issue SUPPL. C, 1999, Pages 67-70

  Muller Serieys, C ^a   Decre D ^a   Benoit, C ^a   Bigot, C ^a   Maubert, B ^a   Carbon, C ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOFLOXACIN; METICILLIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; BLOOD SAMPLING; CONFERENCE PAPER; DRUG ABSORPTION; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; SERUM BACTERICIDAL ACTIVITY; STAPHYLOCOCCUS INFECTION; TIME; TITRIMETRY;

EID: 0032974474     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. CDC. (1997). Interim guidelines for prevention and control of staphylococcal infection associated with reduced susceptibility to vancomycin. Morbidity and Mortality Weekly Report 46, 626-8, 35.
2. Schito, G. C., Debbia, E. A. & Pesce, A. (1996). Susceptibility of respiratory strains of Staphylococcus aureus to fifteen antibiotics: results of a collaborative surveillance study (1992-1993). The Alexander Project Collaborative Group. Journal of Antimicrobial Chemotherapy 38, Suppl. A, 97-106.
3. Brakstad, O. G. & Maeland, J. A. (1997). Mechanisms of methicillin resistance in staphylococci. Acta Pathologica, Microbiologica, et Immunologica Scandinavica 105, 264-76.
4. Eliopoulos, G. M. (1995). In-vitro activity of fluoroquinolones against Gram-positive bacteria. Drugs 49, 48-52.
5. von Eiff, C. & Peters, G. (1996). In-vitro activity of ofloxacin, levofloxacin and D-ofloxacin against staphylococci. Journal of Antimicrobial Chemotherapy 38, 259-63.
6. Yamane, N., Jones, R. N., Frei, R., Hoban, D. J., Pignatari, A. C. & Marco, F. (1994). Levofloxacin in vitro activity: results from an international comparative study with ofloxacin and ciprofloxacin. Journal of Chemotherapy 6, 83-91.
7. Frosco, M. B., Melton, J. L., Stewart, F. P., Kulwich, B. A., Licata, L. & Barrett, J. F. (1996). In vivo efficacies of levofloxacin and ciprofloxacin in acute murine hematogenous pyelonephritis induced by methicillin-susceptible and -resistant Staphylococcus aureus strains. Antimicrobial Agents and Chemotherapy 40, 2529-34.
8. Entenza, J. M., Vouillamoz, J., Glauser, M. P. & Moreillon, P. (1997). Levofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 41, 1662-7.
9. National Committee for Clinical Laboratory Standards. (1990). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Second Edition: Approved Standard M7-A2. NCCLS, Villanova, PA.
10. National Committee for Clinical Laboratory Standards. (1992). Methodology for the Serum Bactericidal Test - Tentative Guideline M21-T. NCCLS, Villanova, PA.
11. Fujimoto, T. & Mitsuhashi, S. (1990). In-vitro antibacterial activity of DR-3355, the S(-) isomer of ofloxacin. Chemotherapy 36, 268-76.
12. Echols, R., Weinstein, M. P., O'Keeffe, B., Shah, A. & Heller, A. H. (1994). Comparative crossover assessment of serum bactericidal activity and pharmacokinetics of ciprofloxacin and ofloxacin. Journal of Antimicrobial Chemotherapy 33, 111-8.
13. Baxter, R., Chapman, J. & Drew, W. L. (1990). Comparison of bactericidal activity of five antibiotics against Staphylococcus aureus. Journal of Infectious Diseases 161, 1023-5.
14. Dan, M., Poch, F., Quassem, C. & Kitzes, R. (1994). Comparative serum bactericidal activities of three doses of ciprofloxacin administered intravenously. Antimicrobial Agents and Chemotherapy 38, 837-41.
15. Israel, D., Gillum, J. G., Turik, M., Harvey, K., Ford, J., Dalton, H. et al. (1993). Pharmacokinetics and serum bactericidal titers of ciprofloxacin and ofloxacin following multiple oral doses in healthy volunteers. Antimicrobial Agents and Chemotherapy 37, 2193-9.
16. Weinstein, M. P., Stratton, C. W., Hawley, H. B., Ackley, A. & Reller, L. B. (1987). Multicenter collaborative evaluation of a standardized serum bactericidal test as a predictor of therapeutic efficacy in acute and chronic osteomyelitis. American Journal of Medicine 83, 218-22.
17. Weinstein, M. P., Stratton, C. W., Ackley, A., Hawley, H. B., Robinson, P. A., Fisher, B. D. et al. (1985). Multicenter collaborative evaluation of a standardized serum bactericidal test as a prognostic indicator in infective endocarditis. American Journal of Medicine 78, 262-9.
18. Wolfson, J. S. & Swartz, M. N. (1985). Drug therapy. Serum bactericidal activity as a monitor of antibiotic therapy. New England Journal of Medicine 312, 968-75.
19. Klastersky, J., Daneau, D., Swings, D. G. & Weerts, D. (1974). Antibacterial activity in serum and urine as a therapeutic guide in bacterial infections. Journal of Infectious Diseases 129, 187-93.
20. Davis, R. & Bryson, H. M. (1994). Levofloxacin. A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy. Drugs 47, 677-700.